This is a firm fixed price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Information Management Services, Inc. (IMS) for access to Surveillance, Epidemiology, and End Results (SEER)-Medicare linked and non-linked data files. The purpose is to investigate the risk of autoimmune diseases in cancer patients compared to those without cancer, and to assess the risk among immune checkpoint inhibitor (ICI) users versus other cancer therapy users. The period of performance is 24 months, with a ceiling value of $61,650. This is a non-competitive procurement utilizing simplified acquisition procedures, as the SEER-Medicare data is a unique and comprehensive resource for the required epidemiological research. IMS is a for-profit Subchapter S corporation with extensive experience supporting federal health research and operations through numerous prime and subcontract awards, particularly with NIH and its institutes.
Generated 7/13/24, 9:16 AM